StratDeck

Two stocks in Biotechnology

argenx vs Zealand Pharma A/S: profit, growth, debt and price compared

argenx is stronger on 4 of 6 figures: sales growth, debt, price for its expected profit and price trend. Zealand Pharma A/S is stronger on 1: profit margin.

Figures as of 18 November 2026Yahoo Finance
Explore argenx's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

argenx and Zealand Pharma A/S side by side
argenxARGX.BRZealand Pharma A/SZEAL.CO
Net margin31.7%Stronger: 67.2%
Revenue growth, past yearStronger: +52.10%−92.00%
Debt to equityStronger: 0.6%2.8%
Forward P/EStronger: 26.9×30.7×
Dividend yield——
AnalystsBuy · 23Buy · 12
From its 200-day averageStronger: +11.9%−28.0%

Share price over the past year

  • argenx+9.4%
  • Zealand Pharma A/S−59.0%

24 Nov 202518 Nov 2026

argenx or Zealand Pharma A/S: which is stronger?

  • ZEAL.CO

    Which is more profitable?

    Zealand Pharma A/S keeps more of each sale as profit: 67.2% against 31.7%.

  • ARGX.BR

    Which is growing its sales faster?

    argenx is growing its sales faster: +52.10% over the past year, against −92.00%.

  • ARGX.BR

    Which has borrowed less?

    argenx has borrowed less: its debt is 0.6% of what its shareholders own, against 2.8% for Zealand Pharma A/S.

  • ARGX.BR

    Which costs less for the profit it is expected to make?

    argenx costs less for the profit it is expected to make: 26.9× its forward earnings, against 30.7×.

  • Which pays more in dividends?

    Neither pays a dividend.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • ARGX.BR

    Which is in the stronger price trend?

    argenx's price is in the stronger trend: 11.9% above its 200-day average, against 28.0% below.

What each company does

ARGX.BRargenx

argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Reports results on 25 February 2027

ZEAL.COZealand Pharma A/S

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

Reports results on 25 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every European healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.